Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents

Current Drug Delivery

Volumn 8, Issue 3, 2011, Pages 299-306

  Singh, Jagbir ^a   Yang, Peng ^a   Michel, Deborah ^a   Verrall, Ronald E ^a   Foldvari, Marianna ^b   Badea, Ildiko ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Amino acid substituted; Cytotoxicity; Gemini surfactants; Gene delivery; Non viral; Physicochemical properties

Indexed keywords

NANOPARTICLE; SURFACTANT;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; EPITHELIUM CELL; GENE EXPRESSION; GENE THERAPY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 79953772311     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720111795256200     Document Type: Article

References (32)

1. Bouard, D.; Alazard-Dany, D.; Cosset, F. L. Viral vectors: from virology to transgene expression. Br. J. Pharmacol., 2009, 157(2), 153-165.
2. Worgall, S.; Wolff, G.; Falck-Pedersen, E.; Crystal, R. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther., 1997, 8(1), 37-44.
3. Tripathy, S. K.; Black, H. B.; Goldwasser, E.; Leiden, J. M. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med., 1996, 2(5), 545-550.
4. Russell, D. W. AAV vectors, insertional mutagenesis, and cancer. Mol. Ther., 2007, 15(10), 1740-1743.
5. Tenenbaum, L.; Lehtonen, E.; Monahan, P. E. Evaluation of risks related to the use of adeno-associated virus-based vectors. Curr. Gene Ther., 2003, 3(6), 545-565.
6. Marshall, E. Clinical trials: gene therapy death prompts review of adenovirus vector. Science, 1999, 286(5448), 2244-2245.
7. Check, E. Gene therapy put on hold as third child develops cancer. Nature, 2005, 433(7026), 561.
8. Grieger, J. C.; Samulski, R. J. Packaging capacity of adenoassociated virus serotypes: impact of larger genomes on infectivity and postentry steps. J. Virol., 2005, 79(15), 9933-9944.
9. Dormond, E.; Meneses-Acosta, A.; Jacob, D.; Durocher, Y.; Gilbert, R.; Perrier, M.; Kamen, A. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection. Biotechnol. Bioeng., 2009, 102(3), 800-810.
10. Wettig, S. D.; Verrall, R. E.; Foldvari, M. Gemini surfactants: a new family of building blocks for non-viral gene delivery systems. Curr. Gene Ther., 2008, 8(1), 9-23.
11. Badea, I.; Verrall, R.; Baca-Estrada, M.; Tikoo, S.; Rosenberg, A.; Kumar, P.; Foldvari, M. In vivo cutaneous interferon-γ gene delivery using novel dicationic (gemini) surfactant-plasmid complexes. J. Gene Med., 2005, 7(9), 1200-1214.
12. Foldvari, M.; Badea, I.; Wettig, S.; Verrall, R.; Bagonluri, M. Structural characterization of novel gemini non-viral DNA delivery systems for cutaneous gene therapy. J. Exp. Nanosci., 2006, 1(2), 165-176.
13. Wettig, S. D.; Badea, I.; Donkuru, M. D.; Verrall, R. E.; Foldvari, M. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles. J. Gene Med., 2007, 9(8), 649-658.
14. Yang, P.; Singh, J.; Wettig, S.; Foldvari, M.; Verrall, R. E.; Badea, I. Enhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticles. Eur. J. Pharm. Biopharm., 2010, 75(3), 311-320.
15. Mislick, K. A.; Baldeschwieler, J. D. Evidence for the role of proteoglycans in cation-mediated gene transfer. P. Natl. Acad. Sci. USA, 1996, 93(22), 12349-12354.
16. Takeuchi, K.; Ishihara, M.; Kawaura, C.; Noji, M.; Furuno, T.; Nakanishi, M. Effect of zeta potential of cationic liposomes containing cationic cholesterol derivatives on gene transfection. FEBS Lett., 1996, 397(2-3), 207-209.
17. Kreiss, P.; Cameron, B.; Rangara, R.; Mailhe, P.; Aguerre-Charriol, O.; Airiau, M.; Scherman, D.; Crouzet, J.; Pitard, B. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucl. Acids Res., 1999, 27(19), 3792-3798.
18. Sakurai, F.; Inoue, R.; Nishino, Y.; Okuda, A.; Matsumoto, O.; Taga, T.; Yamashita, F.; Takakura, Y.; Hashida, M. Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression. J. Control. Release, 2000, 66(2-3), 255-269.
19. Prabha, S.; Zhou, W. Z.; Panyam, J.; Labhasetwar, V. Sizedependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm., 2002, 244(1-2), 105-115.
20. Tseng, W.; Haselton, F. R.; Giorgio, T. D. Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. J. Biol. Chem., 1997, 272(41), 25641-25647.
21. Schuber, F. Influence of polyamines on membrane functions. Biochem. J., 1989, 260(1), 1-10.
22. Xu, Y.; Hui, S.; Frederik, P.; Szoka Jr., F. C. Physicochemical characterization and purification of cationic lipoplexes. Biophys. J., 1999, 77(1), 341-353.
23. Wiethoff, C. M.; Gill, M. L.; Koe, G. S.; Koe, J. G.; Middaugh, C. R. A fluorescence study of the structure and accessibility of plasmid DNA condensed with cationic gene delivery vehicles. J. Pharm. Sci., 2003, 92(6), 1272-1285.
24. Zauner, W.; Ogris, M.; Wagner, E. Polylysine-based transfection systems utilizing receptor-mediated delivery. Adv. Drug Deliv. Rev., 1998, 30(1-3), 97-113.
25. Badea, I. Gemini cationic surfactant-based delivery systems for non-invasive cutaneous gene therapy. PhD Thesis, University of Saskatchewan: Saskatoon, May 2006.
26. Colombo, G.; Soto, P.; Gazit, E. Peptide self-assembly at the nanoscale: a challenging target for computational and experimental biotechnology. Trends Biotechnol., 2007, 25(5), 211-218.
27. Wheeler, C. J.; Sukhu, L.; Yang, G.; Tsai, Y.; Bustamente, C.; Felgner, P.; Norman, J.; Manthorpe, M. Converting an alcohol to an amine in a cationic lipid dramatically alters the co-lipid requirement, cellular transfection activity and the ultrastructure of DNA-cytofectin complexes. BBA-Biomembranes, 1996, 1280(1), 1-11.
28. Bennett, M. J.; Aberle, A. M.; Balasubramaniam, R. P.; Malone, J. G.; Nantz, M. H.; Malone, R. W. Considerations for the design of improved cationic amphiphile-based transfection reagents. J. Liposome Res., 1996, 6(3), 545-565.
29. Hong, S.; Leroueil, P. R.; Janus, E. K.; Peters, J. L.; Kober, M. M.; Islam, M. T.; Orr, B. G.; Baker Jr, J. R.; Holl, M. M. B. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug. Chem., 2006, 17(3), 728-734.
30. Tribet, C.; Vial, F. Flexible macromolecules attached to lipid bilayers: impact on fluidity, curvature, permeability and stability of the membranes. Soft Matter., 2008, 4(1), 68-81.
31. Mecke, A.; Majoros, I. J.; Patri, A. K.; Baker Jr, J. R.; Holl, M. M. B.; Orr, B. G. Lipid bilayer disruption by polycationic polymers: The roles of size and chemical functional group. Langmuir, 2005, 21(23), 10348-10354.
32. Boussif, O.; Lezoualc'h, F.; Zanta, M.; Mergny, M.; Scherman, D.; Demeneix, B.; Behr, J. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U S A, 1995, 92(16), 7297-7301.